联合治疗黄褐斑的研究进展

摘要/Abstract

摘要：

黄褐斑是一种常见的皮肤色素代谢障碍性疾病，因病因及发病机制复杂，单药治疗疗效不佳或不良反应较大，而联合治疗因疗效佳、不良反应小受到医生的亲睐。目前黄褐斑的治疗多样，主要有口服、外用药物，激光或光子疗法，多种方案联合治疗等。黄褐斑的治疗需根据患者病因、病程、临床分型、既往治疗情况等制定个性化治疗方案。多重治疗、序贯治疗或补充治疗应纳入黄褐斑治疗中。

Abstract:

Zhu Liping, Liu Haiyang, Pang Qin, He Li Kunming Medical University, Kunming 650032, China （Zhu LP）; Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650051, China （Liu HY）; Winona Medical Cosmetic Center, Kunming 650100, China （Pang Q）; Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Dermatology and Venereology, Yunnan Engineering and Technology Research Center, Kunming 650032, China （He L） Corresponding author: He Li, Email: helikm2662@126.com 【Abstract】 Melasma is a common cutaneous disorder of pigment metabolism with complex etiology and pathogenesis. Combination therapy has been preferred by dermatologists for better therapeutic effects and less adverse reactions compared with monotherapy. At present, the treatment of melasma is diversiform, mainly including oral or topical drugs, lasers or photon therapy and combination therapy, etc. Individualized treatment is recommended based on etiology, clinical course and types of melasma, as well as previous treatment history. Combination therapy, sequential therapy or supplement therapy should be included in the treatment of melasma.

朱丽萍刘海洋庞勤何黎. 联合治疗黄褐斑的研究进展[J]. 中华皮肤科杂志, 2016, 49(2): 147-150.doi:

参考文献 30

［1］	Gupta AK, Gover MD, Nouri K, et al. The treatment of melasma: a review of clinical trials［J］. Am Acad Dermatol, 2006, 55（6）: 1048⁃1065.
［2］	Cestari T, Arellano I, Hexsel D, et al. Melasma in Latin America: options for therapy and treatment algorithm［J］. Eur Acad Dermatol Venereol, 2009, 23（7）: 760⁃772. DOI: 10.1111/j.1468⁃3083.2009.03251.x.
［3］	Arellano I, Cestari T, Ocampo⁃Candiani J, et al. Preventing melasma recurrence: prescribing a maintenance regimen with aneffective triple combination cream based on long⁃standing clinical severity［J］. Eur Acad Dermatol Venereol, 2012, 26（5）: 611⁃618.
［4］	Gong Z, Lai W, Zhao G, et al. Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double⁃blind, placebo⁃controlled, multicenter, parallel⁃group study［J］. Clin Drug Investig, 2015, 35（6）: 385⁃395. DOI: 10.1007/s40261⁃015⁃0292⁃8.
［5］	Mahajan R, Kanwar AJ, Parsad D, et al. Glycolic Acid peels/azelaic Acid 20 cream combination and low potency triple combination lead to similar reduction in melasma severity in ethnic skin: results of a randomized controlled study［J］. Indian J Dermatol, 2015, 60（2）: 147⁃152. DOI: 10.4103/0019⁃5154.152510.
［6］	Pratchyapruit W, Vashrangsi N, Sindhavananda J, et al. Instru⁃mental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman⁃Willis triple combination therapy: confirmation by using its two different formulae［J］. Skin Res Technol, 2011, 17（2）: 226⁃233. DOI: 10.1111/j.1600⁃0846.2010.00489.x.
［7］	Ibrahim ZA, Gheida SF, Maghraby GM, et al. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma［J］. Cosmet Dermatol, 2015, 14（2）: 113⁃123. DOI: 10.1111/jocd.12143.
［8］	Gold MH1, Biron J. Efficacy of a novel hydroquinone⁃free skin⁃brightening cream in patients with melasma［J］. Cosmet Dermatol, 2011, 10（3）: 189⁃196. DOI: 10.1111/j.1473⁃2165.2011.00573.x.
［9］	Kodali S, Guevara IL, Carrigan CR, et al. A prospective, rando⁃mized, split⁃face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women［J］. Am Acad Dermatol, 2010, 63（6）: 1030⁃1035. DOI: 10.1016/j.jaad.2009.12. 027.
［10］	Hsieh PW, Aljuffali IA, Fang CL, et al. Hydroquinone⁃salicylic acid conjugates as novel anti⁃melasma actives show superior skin targeting compared to the parent drugs［J］. Dermatol Sci, 2014, 76（2）: 120⁃131. DOI: 10.1016/j.jdermsci.2014.08.013.
［11］	Handog EB, Galang DA, Leon⁃Godinez MA, et al. A randomized, double⁃blind, placebo⁃controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women［J］. Int J Dermatol, 2009, 48（8）: 896⁃901. DOI: 10.1111/j.1365⁃4632.2009. 04130.x.
［12］	Kim HS , Kim EK, Jung KE, et al. A split⁃face comparison of low⁃fl uence Q⁃switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q⁃switched Nd: YAG monotherapy for facial melasma in Asian skin［J］. J Cosmet Laser Ther, 2013, 15（3): 143⁃149. DOI: 10.3109/14764172.2013.769274.
［13］	Lee HI, Lim YY, Kim BJ, Kim MN, et al. Clinicopathologic efficacy of copper bromide plus/yellow laser （578 nm with 511 nm） for treatment of melasma in Asian patients［J］. Dermatol Surg, 2010, 36（6）: 885⁃893. DOI: 10.1111/j.1524⁃4725.2010.01564.x.
［14］	Eimpunth S, Wanitphakdeedecha R, Triwongwaranat D, et al. Therapeutic outcome of melasma treatment by dual⁃wavelength （511 and 578 nm） laser in patients with skin phototypes III⁃V［J］. Clin Exp Dermatol, 2014, 39（3）: 292⁃297. DOI: 10.1111/ced.12267.
［15］	Feng XJ, Fu JY, Liu F. Clinical observation on the combined Use of acupuncture and herbal medicine for treatment of chloasma［J］. Tradit Chin Med, 2010, 30（1）: 15⁃17.
［16］	Shin JU, Park J, Oh SH, et al. Oral tranexamic acid enhances the efficacy of low⁃fluence1064⁃Nm Quality⁃Switched neodymium⁃doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial［J］. Dermatol Surg, 2013, 39（3 Pt 1）: 435⁃442. DOI: 10.1111/dsu.12060.
［17］	Jeong SY, Shin JB, Yeo UC, et al. Low⁃fluence Q⁃switched neodymium⁃doped yttrium aluminum garnet laser for melasma with pre⁃ or post⁃treatment triple combination cream［J］. Dermatol Surg, 2010, 36（6）: 909⁃918. DOI: 10.1111/j.1524⁃4725. 2010.01523.x.
［18］	Park KY, Kim DH, Kim HK, et al. A randomized, observer⁃blinded, comparison of combined 1064⁃nm Q⁃switched neodymium⁃doped yttrium⁃aluminium⁃garnet laser plus 30 glycolic acid peel vs. laser monotherapy to treat melasma［J］. Clin Exp Dermatol, 2011, 36（8）: 864⁃870. DOI: 10.1111/j.1365⁃2230.2011.04150.x.
［19］	Vachiramon V, Sahawatwong S, Sirithanabadeekul P. Treatment of melasma in men with low⁃fluence Q⁃switched neodymium⁃doped yttrium⁃aluminum⁃garnet laser versus combined laser and glycolic acid peeling［J］. Dermatol Surg, 2015, 41（4）: 457⁃465. DOI: 10.1097/DSS.0000000000000304.
［20］	Wattanakrai P, Mornchan R, Eimpunth S. Low⁃fluence Q⁃switched neodymium⁃doped yttrium aluminum garnet （1,064 nm） laser for the treatment of facial melasma in Asians［J］. Dermatol Surg, 2010, 36（1）: 76⁃87. DOI: 10.1111/j.1524⁃4725.2009.01383.x.
［21］	Lee DB, Suh HS, Choi YS. A comparative study of low⁃fluence 1064⁃nm Q⁃switched Nd:YAG laser with or without chemical peeling using Jessner′s solution in melasma patients［J］. Dermatolog Treat, 2014, 25（6）: 523⁃528. DOI: 10.3109/09546634. 2013.848261.
［22］	Thierry P, Fontas E, Kang HY, et al. Melasma treatment with pulsed⁃dye laser and triple combination cream: a prospective, randomized, single⁃blind, split⁃face study［J］. Arch Dermatol, 2011, 147（9）: 1106⁃1108. DOI: 10.1001/archdermatol.2011.255.
［23］	Goldman MP, Gold MH, Palm MD, et al. Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive （control） cream and intense pulsed light in patients with moderate to severe melasma［J］. Dermatol Surg, 2011, 37（2）: 224⁃233. DOI: 10.1111/j.1524⁃4725.2010.01849.x.
［24］	Figueiredo SL, Trancoso SS. Single⁃session intense pulsed light combined with stable fixed⁃dose triple combination topical therapy for the treatment of refractory melasma［J］. Dermatol Ther, 2012, 25（5）: 477⁃480. DOI: 10.1111/j.1529⁃8019.2012.01530.x.
［25］	Hong SP, Han SS, Choi SJ, et al. Split⁃face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15 chemical peeling for facial melasma in Asian skin［J］. Cosmet Laser Ther, 2012, 14（2）: 81⁃86. DOI: 10.3109/14764172.2012.655287.
［26］	Kroon MW, Wind BS, Beek JF, et al. Nonablative 1550⁃nm fractional laser therapy versus triple topical therapy forthe treatment of melasma: a randomized controlled pilot study［J］. Am Acad Dermatol, 2011, 64（3）: 516⁃523.
［27］	Wind BS, Kroon MW, Meesters AA, et al. Non⁃ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split⁃face study［J］. Lasers Surg Med, 2010, 42（7）: 607⁃612. DOI: 10.1002/lsm.20937.
［28］	Tourlaki A, Galimberti MG, Pellacani G, et al. Combination of fractional erbium⁃glass laser and topical therapy in melasma resistant to triple⁃combination cream［J］. Dermatolog Treat, 2014, 25（3）: 218⁃222. DOI: 10.3109/09546634.2012.671911.
［29］	Shaikh ZI, Mashood AA. Treatment of refractory melasma with combination of topical 5 magnesium ascorbyl phosphate and fluorescent pulsed light in Asian patients［J］. Int J Dermatol, 2014, 53（1）: 93⁃99. DOI: 10.1111/ijd.12195.
［30］	Cameli N, Abril E, Mariano M, et al. Combined use of monopolar radiofrequency and transdermal drug delivery in the treatment of melasma［J］. Dermatol Surg, 2014, 40（7）: 748⁃755. DOI: 10. 1111/dsu.0000000000000029.